19 October 2011
Healthcare research has provided new guidelines for the prevention and early detection of cervical cancer.
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) have proposed a new set of suggestions for medical professionals to consider when testing for the cancer.
Women are advised to reduce the amount of smear tests they have in their lifetime by the new guidelines, which propose that minimising them will reduce the risk of damage as well as maintain the benefits of getting tested.
Researchers at the centres suggested that the smear test should be a part of a co-testing scheme where women over 30 are checked for the sexually transmitted infection human papillomavirus (HPV), which affects over 50 per cent of sexually active adults.
A final draft of the guidelines is expected from the American Cancer Society in mid-2012.
Debbie Saslow, PhD, director of breast and gynaecologic cancer for the American Cancer Society, said: "These draft recommendations are being presented for review by interested individuals and stakeholders, primarily clinicians and researchers, who are invited to provide feedback through a web-based open comment period."
Posted By Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.